Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Inventory: 2020-2025

Historic Inventory for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to $45.3 million.

  • Maravai Lifesciences Holdings' Inventory fell 10.31% to $45.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.3 million, marking a year-over-year decrease of 10.31%. This contributed to the annual value of $50.1 million for FY2024, which is 2.56% down from last year.
  • Maravai Lifesciences Holdings' Inventory amounted to $45.3 million in Q3 2025, which was down 2.87% from $46.7 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' Inventory's 5-year high stood at $62.4 million during Q3 2022, with a 5-year trough of $43.2 million in Q4 2022.
  • Its 3-year average for Inventory is $49.5 million, with a median of $49.8 million in 2025.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Inventory soared by 54.82% in 2021 and then fell by 21.28% in 2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Inventory (Quarterly) stood at $51.6 million in 2021, then fell by 16.30% to $43.2 million in 2022, then climbed by 19.11% to $51.4 million in 2023, then declined by 2.56% to $50.1 million in 2024, then dropped by 10.31% to $45.3 million in 2025.
  • Its Inventory was $45.3 million in Q3 2025, compared to $46.7 million in Q2 2025 and $49.8 million in Q1 2025.